Cdx1 and Cdx2 Function as tumor suppressors

Journal of Biological Chemistry

Volumn 289, Issue 48, 2014, Pages 33343-33354

  Hryniuk, Alexa ^a   Grainger, Stephanie ^a   Savory, Joanne G A ^a   Lohnes, David ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA SEQUENCES; GENES; TRANSCRIPTION; TRANSCRIPTION FACTORS; TUMORS;

CANONICAL WNT SIGNALING; COLORECTAL CANCER; GASTROINTESTINAL TRACT; HOMEODOMAIN TRANSCRIPTION FACTOR; INTESTINAL TUMORIGENESIS; SMALL INTESTINE; TUMOR SUPPRESSORS; TUMORIGENESIS;

DISEASES;

TRANSCRIPTION FACTOR CDX1; TRANSCRIPTION FACTOR CDX2; APC PROTEIN; CDX1 PROTEIN, MOUSE; CDX2 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CDX1 GENE; CDX2 GENE; COLORECTAL CANCER; CONTROLLED STUDY; GENE FUNCTION; GENE MUTATION; INCIDENCE; LONGITUDINAL STUDY; MOUSE; NONHUMAN; NULL ALLELE; PHENOTYPE; POLYPOSIS; TUMOR SUPPRESSOR GENE; WNT SIGNALING PATHWAY; ANIMAL; COLORECTAL TUMOR; EXPERIMENTAL NEOPLASM; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; COLORECTAL NEOPLASMS; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84912058804     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.583823     Document Type: Article

References (75)

1. Näthke, I. S. (2004) The adenomatous polyposis coli protein: the Achilles heel of the gut epithelium. Annu. Rev. Cell Dev. Biol. 20, 337-366
2. Polakis, P. (2007) The many ways of Wnt in cancer. Curr. Opin. Genet. Dev. 17, 45-51
3. Halberg, R. B., Katzung, D. S., Hoff, P. D., Moser, A. R., Cole, C. E., Lubet, R. A., Donehower, L. A., Jacoby, R. F., and Dove, W. F. (2000) Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Proc. Natl. Acad. Sci. U.S.A. 97, 3461-3466
4. Moser, A. R., Pitot, H. C., and Dove, W. F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324
5. Clevers, H. (2006) Wnt/β-catenin signaling in development and disease. Cell 127, 469-480
6. Sansom, O. J., Meniel, V., Wilkins, J. A., Cole, A. M., Oien, K. A., Marsh, V., Jamieson, T. J., Guerra, C., Ashton, G. H., Barbacid, M., and Clarke, A. R. (2006) Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo. Proc. Natl. Acad. Sci. U.S.A. 103, 14122-14127
7. Hamamoto, T., Beppu, H., Okada, H., Kawabata, M., Kitamura, T., Miyazono, K., and Kato, M. (2002) Compound disruption of Smad2 accelerates malignant progression of intestinal tumors in apc knockout mice. Cancer Res. 62, 5955-5961
8. Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M. F., and Taketo, M. M. (1998) Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92, 645-656
9. Cortina, C., Palomo-Ponce, S., Iglesias, M., Fernández-Masip, J. L., Vivancos, A., Whissell, G., Humà, M., Peiró, N., Gallego, L., Jonkheer, S., Davy, A., Lloreta, J., Sancho, E., and Batlle, E. (2007) EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat. Genet. 39, 1376-1383
10. Chawengsaksophak, K., James, R., Hammond, V. E., Köntgen, F., and Beck, F. (1997) Homeosis and intestinal tumours in Cdx2 mutant mice. Nature 386, 84-87
11. Gao, N., White, P., and Kaestner, K. H. (2009) Establishment of intestinal identity and epithelial-mesenchymal signaling by Cdx2. Dev. Cell 16, 588-599
12. Grainger, S., Savory, J. G., and Lohnes, D. (2010) Cdx2 regulates patterning of the intestinal epithelium. Dev. Biol. 339, 155-165
13. Hryniuk, A., Grainger, S., Savory, J. G., and Lohnes, D. (2012) Cdx function is required for maintenance of intestinal identity in the adult. Dev. Biol. 363, 426-437
14. Verzi, M. P., Shin, H., Ho, L. L., Liu, X. S., and Shivdasani, R. A. (2011) Essential and redundant functions of Caudal family proteins in activating adult intestinal genes. Mol. Cell Biol. 31, 2026-2039
15. Verzi, M. P., Shin, H., He, H. H., Sulahian, R., Meyer, C. A., Montgomery, R. K., Fleet, J. C., Brown, M., Liu, X. S., and Shivdasani, R. A. (2010) Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2. Dev. Cell 19, 713-726
16. Subramanian, V., Meyer, B. I., and Gruss, P. (1995) Disruption of the murine homeobox gene Cdx1 affects axial skeletal identities by altering the mesodermal expression domains of Hox genes. Cell 83, 641-653
17. Baba, Y., Nosho, K., Shima, K., Freed, E., Irahara, N., Philips, J., Meyerhardt, J. A., Hornick, J. L., Shivdasani, R. A., Fuchs, C. S., and Ogino, S. (2009) Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer. Clin. Cancer Res. 15, 4665-4673
18. Hinoi, T., Tani, M., Lucas, P. C., Caca, K., Dunn, R. L., Macri, E., Loda, M., Appelman, H. D., Cho, K. R., and Fearon, E. R. (2001) Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am. J. Pathol. 159, 2239-2248
19. Lugli, A., Tzankov, A., Zlobec, I., and Terracciano, L. M. (2008) Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status. Mod. Pathol. 21, 1403-1412
20. Bonhomme, C., Duluc, I., Martin, E., Chawengsaksophak, K., Chenard, M. P., Kedinger, M., Beck, F., Freund, J. N., and Domon-Dell, C. (2003) The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development. Gut 52, 1465-1471
21. Su, L. K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., and Dove, W. F. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-670
22. Savory, J. G., Bouchard, N., Pierre, V., Rijli, F. M., De Repentigny, Y., Kothary, R., and Lohnes, D. (2009) Cdx2 regulation of posterior development through non-Hox targets. Development 136, 4099-4110
23. Schefe, J. H., Lehmann, K. E., Buschmann, I. R., Unger, T., and Funke-Kaiser, H. (2006) Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula. J. Mol. Med. 84, 901-910
24. +/- compound mutant mice. Nat. Genet. 35, 323-330
25. Batlle, E., Bacani, J., Begthel, H., Jonkheer, S., Gregorieff, A., van de Born, M., Malats, N., Sancho, E., Boon, E., Pawson, T., Gallinger, S., Pals, S., and Clevers, H. (2005) EphB receptor activity suppresses colorectal cancer progression. Nature 435, 1126-1130
26. Batlle, E., Henderson, J. T., Beghtel, H., van den Born, M. M., Sancho, E., Huls, G., Meeldijk, J., Robertson, J., van de Wetering, M., Pawson, T., and Clevers, H. (2002) β-Catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111, 251-263
27. Gregorieff, A., and Clevers, H. (2005) Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev. 19, 877-890
28. Pasquale, E. B. (2005) Eph receptor signalling casts a wide net on cell behaviour. Nat. Rev. Mol. Cell Biol. 6, 462-475
29. Clevers, H., and Batlle, E. (2006) EphB/EphrinB receptors and Wnt signaling in colorectal cancer. Cancer Res. 66, 2-5
30. Bakaris, S., Cetinkaya, A., Ezberci, F., and Ekerbicer, H. (2008) Expression of homeodomain protein CDX2 in colorectal adenoma and adenocarcinoma. Histol. Histopathol. 23, 1043-1047
31. Kaimaktchiev, V., Terracciano, L., Tornillo, L., Spichtin, H., Stoios, D., Bundi, M., Korcheva, V., Mirlacher, M., Loda, M., Sauter, G., and Corless, C. L. (2004) The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod. Pathol. 17, 1392-1399
32. Sporn, M. B. (1996) The war on cancer. Lancet 347, 1377-1381
33. Thiery, J. P. (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15, 740-746
34. Sipos, F., and Galamb, O. (2012) Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon. World J. Gastroenterol. 18, 601-608
35. Akhurst, R. J., and Derynck, R. (2001) TGF-β signaling in cancer: a double-edged sword. Trends Cell Biol. 11, S44-S51
36. Derynck, R., Akhurst, R. J., and Balmain, A. (2001) TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29, 117-129
37. Stevenson, B. R., Siliciano, J. D., Mooseker, M. S., and Goodenough, D. A. (1986) Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J. Cell Biol. 103, 755-766
38. Sodir, N. M., Chen, X., Park, R., Nickel, A. E., Conti, P. S., Moats, R., Bading, J. R., Shibata, D., and Laird, P. W. (2006) Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice. Cancer Res. 66, 8430-8438
39. Yoshinaga, K., Obata, H., Jurukovski, V., Mazzieri, R., Chen, Y., Zilberberg, L., Huso, D., Melamed, J., Prijatelj, P., Todorovic, V., Dabovic, B., and Rifkin, D. B. (2008) Perturbation of transforming growth factor (TGF)-β1 association with latent TGF-β binding protein yields inflammation and tumors. Proc. Natl. Acad. Sci. U.S.A. 105, 18758-18763
40. Hasson, R. M., Briggs, A., Carothers, A. M., Davids, J. S., Wang, J., Javid, S. H., Cho, N. L., and Bertagnolli, M. M. (2014) Estrogen receptor α or β loss in the colon of Min/+ mice promotes crypt expansion and impairs TGFβ and HNF3β signaling. Carcinogenesis 35, 96-102
41. Cho, N. L., Javid, S. H., Carothers, A. M., Redston, M., and Bertagnolli, M. M. (2007) Estrogen receptors α and β are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice. Cancer Res. 67, 2366-2372
42. Muñoz, N. M., Upton, M., Rojas, A., Washington, M. K., Lin, L., Chytil, A., Sozmen, E. G., Madison, B. B., Pozzi, A., Moon, R. T., Moses, H. L., and Grady, W. M. (2006) Transforming growth factor β receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation. Cancer Res. 66, 9837-9844
43. Sekiya, T., Adachi, S., Kohu, K., Yamada, T., Higuchi, O., Furukawa, Y., Nakamura, Y., Nakamura, T., Tashiro, K., Kuhara, S., Ohwada, S., and Akiyama, T. (2004) Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-β signaling, as a target of the β-catenin pathway in colorectal tumor cells. J. Biol. Chem. 279, 6840-6846
44. Zhu, Y., Richardson, J. A., Parada, L. F., and Graff, J. M. (1998) Smad3 mutant mice develop metastatic colorectal cancer. Cell 94, 703-714
45. Itoh, F., Divecha, N., Brocks, L., Oomen, L., Janssen, H., Calafat, J., Itoh, S., and Dijke Pt, P. (2002) The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-β/Smad signalling. Genes Cells 7, 321-331
46. Runyan, C. E., Hayashida, T., Hubchak, S., Curley, J. F., and Schnaper, H. W. (2009) Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype. J. Biol. Chem. 284, 25181-25189
47. Funaba, M., Zimmerman, C. M., and Mathews, L. S. (2002) Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase. J. Biol. Chem. 277, 41361-41368
48. Brown, J. D., DiChiara, M. R., Anderson, K. R., Gimbrone, M. A., Jr, and Topper, J. N. (1999) MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells. J. Biol. Chem. 274, 8797-8805
49. Porsch, H., Mehić, M., Olofsson, B., Heldin, P., and Heldin, C. H. (2014) Platelet-derived growth factor β-receptor, transforming growth factor β type I receptor, and CD44 protein modulate each other's signaling and stability. J. Biol. Chem. 289, 19747-19757
50. Grady, W. M., and Markowitz, S. D. (2002) Genetic and epigenetic alterations in colon cancer. Annu. Rev. Genomics Hum. Genet. 3, 101-128
51. Witek, M. E., Nielsen, K., Walters, R., Hyslop, T., Palazzo, J., Schulz, S., and Waldman, S. A. (2005) The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas. Clin. Cancer Res. 11, 8549-8556
52. Subtil, C., Guérin, E., Schneider, A., Chenard, M. P., Martin, E., Domon-Dell, C., Duluc, I., Brabletz, T., Kedinger, M., Duclos, B., Gaub, M. P., and Freund, J. N. (2007) Frequent rearrangements and amplification of the CDX2 homeobox gene in human sporadic colorectal cancers with chromosomal instability. Cancer Lett. 247, 197-203
53. Salari, K., Spulak, M. E., Cuff, J., Forster, A. D., Giacomini, C. P., Huang, S., Ko, M. E., Lin, A. Y., van de Rijn, M., and Pollack, J. R. (2012) CDX2 is an amplified lineage-survival oncogene in colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 109, E3196-E3205
54. Domon-Dell, C., Schneider, A., Moucadel, V., Guerin, E., Guenot, D., Aguillon, S., Duluc, I., Martin, E., Iovanna, J., Launay, J. F., Duclos, B., Chenard, M. P., Meyer, C., Oudet, P., Kedinger, M., Gaub, M. P., and Freund, J. N. (2003) Cdx1 homeobox gene during human colon cancer progression. Oncogene 22, 7913-7921
55. Guo, R. J., Huang, E., Ezaki, T., Patel, N., Sinclair, K., Wu, J., Klein, P., Suh, E. R., and Lynch, J. P. (2004) Cdx1 inhibits human colon cancer cell proliferation by reducing β-catenin/T-cell factor transcriptional activity. J. Biol. Chem. 279, 36865-36875
56. Pilozzi, E., Onelli, M. R., Ziparo, V., Mercantini, P., and Ruco, L. (2004) CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation. J. Pathol. 204, 289-295
57. Wong, N. A., Britton, M. P., Choi, G. S., Stanton, T. K., Bicknell, D. C., Wilding, J. L., and Bodmer, W. F. (2004) Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines. Proc. Natl. Acad. Sci. U.S.A. 101, 574-579
58. Beck, F., Chawengsaksophak, K., Luckett, J., Giblett, S., Tucci, J., Brown, J., Poulsom, R., Jeffery, R., and Wright, N. A. (2003) A study of regional gut endoderm potency by analysis of Cdx2 null mutant chimaeric mice. Dev. Biol. 255, 399-406
59. Suh, E. R., Ha, C. S., Rankin, E. B., Toyota, M., and Traber, P. G. (2002) DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines. J. Biol. Chem. 277, 35795-35800
60. Bonhomme, C., Calon, A., Martin, E., Robine, S., Neuville, A., Kedinger, M., Domon-Dell, C., Duluc, I., and Freund, J. N. (2008) Cdx1, a dispensable homeobox gene for gut development with limited effect in intestinal cancer. Oncogene 27, 4497-4502
61. Hong, K. D., Lee, D., Lee, Y., Lee, S. I., and Moon, H. Y. (2013) Reduced CDX2 expression predicts poor overall survival in patients with colorectal cancer. Am. Surg. 79, 353-360
62. Galandiuk, S., Fazio, V. W., Jagelman, D. G., Lavery, I. C., Weakley, F. A., Petras, R. E., Badhwar, K., McGonagle, B., Eastin, K., and Sutton, T. (1987) Villous and tubulovillous adenomas of the colon and rectum. A retrospective review, 1964-1985. Am. J. Surg. 153, 41-47
63. Rubio, D., Garcia, S., De la Cueva, T., Paz, M. F., Lloyd, A. C., Bernad, A., and Garcia-Castro, J. (2008) Human mesenchymal stem cell transformation is associated with a mesenchymal-epithelial transition. Exp. Cell Res. 314, 691-698
64. Lorentz, O., Duluc, I., Arcangelis, A. D., Simon-Assmann, P., Kedinger, M., and Freund, J. N. (1997) Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation. J. Cell Biol. 139, 1553-1565
65. Funakoshi, S., Kong, J., Crissey, M. A., Dang, L., Dang, D., and Lynch, J. P. (2010) Intestine-specific transcription factor Cdx2 induces E-cadherin function by enhancing the trafficking of E-cadherin to the cell membrane. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G1054-G1067
66. Gulhati, P., Bowen, K. A., Liu, J., Stevens, P. D., Rychahou, P. G., Chen, M., Lee, E. Y., Weiss, H. L., O'Connor, K. L., Gao, T., and Evers, B. M. (2011) mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 71, 3246-3256
67. Ku, J. L., Park, S. H., Yoon, K. A., Shin, Y. K., Kim, K. H., Choi, J. S., Kang, H. C., Kim, I. J., Han, I. O., and Park, J. G. (2007) Genetic alterations of the TGF-β signaling pathway in colorectal cancer cell lines: a novel mutation in Smad3 associated with the inactivation of TGF-β-induced transcriptional activation. Cancer Lett. 247, 283-292
68. Takayama, T., Miyanishi, K., Hayashi, T., Sato, Y., and Niitsu, Y. (2006) Colorectal cancer: genetics of development and metastasis. J. Gastroenterol. 41, 185-192
69. Kim, B. G., Li, C., Qiao, W., Mamura, M., Kasprzak, B., Anver, M., Wolfraim, L., Hong, S., Mushinski, E., Potter, M., Kim, S. J., Fu, X. Y., Deng, C., and Letterio, J. J. (2006) Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441, 1015-1019
70. Bakkebø, M., Huse, K., Hilden, V. I., Forfang, L., Myklebust, J. H., Smeland, E. B., and Oksvold, M. P. (2012) SARA is dispensable for functional TGF-β signaling. FEBS Lett. 586, 3367-3372
71. Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., Teague, J. W., Campbell, P. J., Stratton, M. R., and Futreal, P. A. (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39, D945-D950
72. Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., Szabo, S., Buckhaults, P., Farrell, C., Meeh, P., Markowitz, S. D., Willis, J., Dawson, D., Willson, J. K., Gazdar, A. F., Hartigan, J., Wu, L., Liu, C., Parmigiani, G., Park, B. H., Bachman, K. E., Papadopoulos, N., Vogelstein, B., Kinzler, K. W., and Velculescu, V. E. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274
73. Grainger, S., Lam, J., Savory, J. G., Mears, A. J., Rijli, F. M., and Lohnes, D. (2012) Cdx regulates Dll1 in multiple lineages. Dev. Biol. 361, 1-11
74. Pardali, K., and Moustakas, A. (2007) Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta 1775, 21-62
75. Chung, D. C. (2000) The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology 119, 854-865